The weekly litigation news digest is live. Subscribe now

IP Verse

Identifying Patient Response To S1P Receptor Modulator Administration - EP3647783

The patent EP3647783 was granted to Novartis on Dec 21, 2022. The application was filed on Apr 19, 2013 under application number EP19204477A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3647783

NOVARTIS
Application Number
EP19204477A
Filing Date
Apr 19, 2013
Status
Granted And Under Opposition
Nov 18, 2022
Publication Date
Dec 21, 2022
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (4)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
KRAUS & LEDERER PARTGMBBSep 21, 2023KRAUS & LEDERER PARTGMBBADMISSIBLE
SYNTHONSep 21, 2023HAMM & WITTKOPPADMISSIBLE
VENNER SHIPLEYSep 21, 2023RUSSELLADMISSIBLE
KILBURN & STRODESep 20, 2023LEONARDADMISSIBLE

Patent Citations (5) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONWO2010072703
OPPOSITIONWO2010072703
OPPOSITIONWO2011041146
OPPOSITIONWO2014161606
SEARCHWO2010072703

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents